Normal tissues use the BM, which is constructed collaboratively by epithelial and stromal cells, for a variety of functions; many more may be revealed in the future. By of these spheres, which lack attachment to the BM, those used in anticancer therapy (see Figure 1) . are eliminated by apoptosis as well as by nonapoptotic The basement membrane (BM) is a specialized form death mechanisms. This model seems to recapitulate of the ECM that is found in several forms throughout the steps by which a mammary duct is created, which the body. In epithelial tissues, a major BM separates depend upon the hollowing-out of solid cylinders of epithe epithelial cell population from the mixture of mesenthelial cells in order to form a lumen. chymal cell types that is collectively termed the stroma.
. Moreover, the prosurvival funchas the distinct advantage that it takes into account physiologically relevant interactions while still being tion of this integrin-ECM interaction may help explain why certain tumor types home to particular tissues duramenable to facile genetic manipulation and biochemical analysis.
ing metastatic spread. By finding a new home where these interactions are maximized, the tumor cells more The research described in the paper of Weaver et al. describes a related theme. However, here the establisheffectively ensure their own survival. Research in the postgenomic era is providing cancer ment of proper polarized structures is shown to promote cell survival in response to externally applied agents biologists with an unprecedented number of genes and pathways that are implicated in disease initiation and that induce apoptosis. These authors employ similar 3D culture models, using both normal and malignant MECs.
progression. Sorting through this complexity is a major challenge for the field. While in vivo models have the The tethering of these cells to ECM, specifically to a BM-like substrate, is mediated in large part by integrin advantage of physiological relevance, they are limited in throughput and often difficult to dissect biochemireceptors, which enable attachment of MECs via ␣6 and cally. 3D culture systems, as exemplified by the work of Debnath, Weaver, and colleagues, offer a powerful alternative way of screening large numbers of genes and associated processes in a setting that takes into account the critical interaction of cells with their neighbors and with their environment. Research in this arena begins to build the long-needed bridge between intracellular signaling biochemistry and the changes in tissue morphology that are observed as cells advance progressively down the road toward malignancy. Suddenly, the study of cancer cells in two dimensions seems quaint, if not archaic.
